Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$668K Sell
12,171
-1,160
-9% -$61.3K 0.01% 835
2026
Q1
$736K Sell
13,331
-2,803
-17% -$152K 0.01% 818
2025
Q4
$791K Buy
16,134
+3,730
+30% +$174K 0.01% 763
2025
Q3
$535K Sell
12,404
-3,768
-23% -$147K 0.01% 751
2025
Q2
$621K Buy
16,172
+1,353
+9% +$51.7K 0.01% 656
2025
Q1
$574K Buy
14,819
+5,094
+52% +$186K 0.01% 656
2024
Q4
$329K Sell
9,725
-581
-6% -$20.9K 0.01% 794
2024
Q3
$421K Buy
+10,306
New +$422K 0.01% 629
2019
Q4
Sell
-3,726
Closed -$201K 170
2019
Q3
$201K Buy
+3,726
New +$192K 0.09% 138

Other funds holding GSK

World Investment Advisors's GSK Position: Q2 2026 in Review

World Investment Advisors reduced its GSK (GSK) stake by 8.7% in Q2 2026, selling an estimated $61.3K and leaving 12,171 shares worth $668K. The position accounts for 0.01% of the portfolio, ranked #835.

World Investment Advisors first reported a position in GSK in Q3 2019 and has held it in 9 quarters since. The position peaked at $791K in Q4 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • World Investment Advisors held 12,171 shares of GSK worth $668K as of Q2 2026.
  • World Investment Advisors sold 1,160 GSK shares in Q2 2026, an estimated $61.3K.
  • GSK made up 0.01% of World Investment Advisors's portfolio in Q2 2026, its #835 holding.
  • World Investment Advisors first reported a position in GSK in Q3 2019 and has held it in 9 quarters since.
  • World Investment Advisors's GSK position peaked at $791K in Q4 2025.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.